These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36106692)
1. Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice. Ogger PP; Garcia Martín M; Michalaki C; Zhou J; Brown JC; Du Y; Miah KM; Habib O; Hyde SC; Gill DR; Barclay WS; Johansson C Eur J Immunol; 2022 Nov; 52(11):1768-1775. PubMed ID: 36106692 [TBL] [Abstract][Full Text] [Related]
2. Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection. Katzman C; Israely T; Melamed S; Politi B; Sittner A; Yahalom-Ronen Y; Weiss S; Abu Rass R; Zamostiano R; Bacharach E; Ehrlich M; Paran N; Nissim L Viruses; 2021 Dec; 14(1):. PubMed ID: 35062215 [TBL] [Abstract][Full Text] [Related]
3. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094 [TBL] [Abstract][Full Text] [Related]
4. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
5. CCR2 Signaling Restricts SARS-CoV-2 Infection. Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952 [TBL] [Abstract][Full Text] [Related]
7. [Interaction between SARS-CoV-2 and Host Innate Immunity]. Duan XQ; Xie H; Chen LM Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592 [TBL] [Abstract][Full Text] [Related]
8. Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. Goritzka M; Durant LR; Pereira C; Salek-Ardakani S; Openshaw PJ; Johansson C J Virol; 2014 Jun; 88(11):6128-36. PubMed ID: 24648449 [TBL] [Abstract][Full Text] [Related]
9. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses. Kouwaki T; Nishimura T; Wang G; Oshiumi H Front Immunol; 2021; 12():700926. PubMed ID: 34249006 [TBL] [Abstract][Full Text] [Related]
10. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options. Znaidia M; Demeret C; van der Werf S; Komarova AV Viruses; 2022 Jun; 14(6):. PubMed ID: 35746718 [TBL] [Abstract][Full Text] [Related]
11. Human Nasal and Lung Tissues Infected Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170 [TBL] [Abstract][Full Text] [Related]
14. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage. Amor S; Fernández Blanco L; Baker D Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971 [TBL] [Abstract][Full Text] [Related]
15. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection. Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway. Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802 [TBL] [Abstract][Full Text] [Related]
17. Type I and III interferon responses in SARS-CoV-2 infection. Kim YM; Shin EC Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323 [TBL] [Abstract][Full Text] [Related]
19. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19. Zhang J; Zhao C; Zhao W Front Immunol; 2021; 12():633769. PubMed ID: 33912161 [TBL] [Abstract][Full Text] [Related]
20. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection. Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]